Genomic Profiling Systems Company Profile

03:29 EDT 24th June 2018 | BioPortfolio

Genomic Profiling Systems, Inc. (GPS) is developing pioneering products to address the significant need for rapid microbial and molecular analysis in industrial microbiology and healthcare. GPS's suite of technologies for detecting microbes and molecules provides tests that are rapid, quantitative and ultra-sensitive while being simple, user-friendly, and cost-effective to implement.


One Oak Park Drive, 2nd Floor
United States of America


Phone: 781-271-1444
Fax: 781-271-9905

News Articles [961 Associated News Articles listed on BioPortfolio]

Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy

Dr Miyamoto speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy. ...

Wamberg Genomic Advisors joins with the American Cancer Society to Drive Funds for Lifesaving ...

Cancer Guardian is an exclusive program that provides access to leading comprehensive genomic profiling at the time of a cancer diagnosis. Information from comprehensive genomic Read more...

Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling

At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS.

Foundation Medicine and its Collaborators Present New Findings Supporting Comprehensive Genomic Profiling for Targeted Treatment

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced the presentation of new findings at the American Association for Cancer Research (AACR) Annual Meet...

Comprehensive genomic profiling in tumour analysis

Dr Jeffrey Ross presents at ecancer's Milan Summit on Precision Medicine 2018 about genetic profiling of tumours with a particular focus on relapsed breast cancer patients and lung cancer. He begins ...

DIAN, Roche, Foundation in Chinese genomic profiling deal

Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma

Evolution of Genetic Testing in Breast Cancer Continues

Michael Simon, MD, MPH, discusses advances in genetic testing for breast cancer, highlighting the overlap between genomic risk assessment and tumor genomic profiling.

PubMed Articles [2009 Associated PubMed Articles listed on BioPortfolio]

Data systems, genomic data and expertise of doctors.

Introduction of genomic data into health care requires willingness from physicians to adopt decision support systems as well as genomic information as part of their work. In the interview study, docto...

System wide analysis unravels differential regulation and in vivo essentiality of VapBC TA systems from Mycobacterium tuberculosis.

Toxin-antitoxin (TA) systems are bicistronic genetic modules that are ubiquitously present in bacterial genomes. Mycobacterium tuberculosis (Mtb) genome encodes for 90 putative TA systems and these ar...

Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.

We aimed at identifying deleterious genomic alterations from untreated head and neck squamous cell carcinoma (HNSCC) patients, and assessing their prognostic value.

DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: A pilot study.

To characterise the genomic DNA (gDNA) yield from urine and quality of derived methylation data generated from the widely used Illuminia Infinium MethylationEPIC (HM850K) platform and compare this wit...

Using Genomic Sequencing to Improve Management in Melanoma.

Rapidly advancing genomic sequencing technologies are changing all areas of cancer, from diagnosis to surveillance, and prognostication to treatment. The role of genomic testing in melanoma is expandi...

Clinical Trials [1577 Associated Clinical Trials listed on BioPortfolio]

Advanced Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

The objective of this protocol is to characterize advanced cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcome...

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

The primary objective is to examine the impact on progression-free survival of targeted therapy for breast cancer suggested by proteomic and genomic profiling.

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Overall survival rates for patients with metastatic NSCLC are poor utilizing conventional cytotoxic chemotherapy approaches. However, a subset of patients harbor genomic driver mutations, ...

Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

With the increased availability of next-generation sequencing, oncologists are starting to incorporate genomic profiling into routine care of cancer patients. If a genomic alteration is id...

Genomic Testing and Resulting Medical Decisions

There is no evidence available about which molecular profiling methods are currently used for cancer patients in Austrian clinical practice. The construction of the registry proposed as a ...

Companies [1688 Associated Companies listed on BioPortfolio]

Genomic Profiling Systems

Genomic Profiling Systems, Inc. (GPS) is developing pioneering products to address the significant need for rapid microbial and molecular analysis in industrial microbiology and healthcare. GPS's suit...

Genomic Health

Genomic Health gives cancer patients and physicians insight needed to help make quality treatment decisions. is designed to help patients, caregivers and healthcare professionals und...

KEW, Inc.

KEW, Inc. is a privately-held comprehensive genomic profiling company with headquarters in Cambridge, MA, USA., dedicated to revolutionizing cancer care by providing therapeutic o...

Genomic Technologies

Genomic Technologies utilizes its proprietary instrument control software and well proven mechanical systems for rapid development of synthesis platforms ranging from analytical to preparative scale s...

Genomic Systems

Genomic Systems is a privately held start-up biotechnology company that is in-licensing, developing and commercializing novel targeted therapeutics that address serious unmet medi...

More Information about "Genomic Profiling Systems" on BioPortfolio

We have published hundreds of Genomic Profiling Systems news stories on BioPortfolio along with dozens of Genomic Profiling Systems Clinical Trials and PubMed Articles about Genomic Profiling Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genomic Profiling Systems Companies in our database. You can also find out about relevant Genomic Profiling Systems Drugs and Medications on this site too.

Quick Search


Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record